Molecular Imaging (Feb 2016)

The Effects of Physiological and Methodological Determinants on F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model

  • Steven Deleye MSc,
  • Ann-Marie Waldron MSc,
  • Jill C. Richardson PhD,
  • Mark Schmidt PhD,
  • Xavier Langlois PhD,
  • Sigrid Stroobants MD, PhD,
  • Steven Staelens PhD

DOI
https://doi.org/10.1177/1536012115624919
Journal volume & issue
Vol. 15

Abstract

Read online

Introduction: In this study, the influence of physiological determinants on 18F-fluoro- d -glucose ( 18 F-FDG) brain uptake was evaluated in a mouse model of Alzheimer disease. Materials and Methods: TASTPM (Tg) and age-matched C57BL/6 J (WT) mice were fasted for 10 hours, while another group was fasted for 20 hours to evaluate the effect of fasting duration. The effect of repeatedly scanning was evaluated by scanning Tg and WT mice at days 1, 4, and 7. Brain 18 F-FDG uptake was evaluated in the thalamus being the most indicative region. Finally, the cerebellum was tested as a reference region for the relative standard uptake value (rSUV). Results: When correcting the brain uptake for glucose, the effect of different fasting durations was attenuated and the anticipated hypometabolism in Tg mice was demonstrated. Also, with repeated scanning, the brain uptake values within a group and the hypometabolism of the Tg mice only remained stable over time when glucose correction was applied. Finally, hypometabolism was also observed in the cerebellum, yielding artificially higher rSUV values for Tg mice. Conclusion: Corrections for blood glucose levels have to be applied when semiquantifying 18 F-FDG brain uptake in mouse models for AD. Potential reference regions for normalization should be thoroughly investigated to ensure that they are not pathologically affected also by afferent connections.